67 related articles for article (PubMed ID: 10544040)
1. Structural dependence of the cellular isoform of prion protein on solvent: spectroscopic characterization of an intermediate conformation.
Pergami P; Bramanti E; Ascoli GA
Biochem Biophys Res Commun; 1999 Nov; 264(3):972-8. PubMed ID: 10544040
[TBL] [Abstract][Full Text] [Related]
2. Physical studies of conformational plasticity in a recombinant prion protein.
Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
[TBL] [Abstract][Full Text] [Related]
3. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
[TBL] [Abstract][Full Text] [Related]
4. Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein.
Wille H; Prusiner SB; Cohen FE
J Struct Biol; 2000 Jun; 130(2-3):323-38. PubMed ID: 10940236
[TBL] [Abstract][Full Text] [Related]
5. The role of the 132-160 region in prion protein conformational transitions.
Torrent J; Alvarez-Martinez MT; Liautard JP; Balny C; Lange R
Protein Sci; 2005 Apr; 14(4):956-67. PubMed ID: 15772306
[TBL] [Abstract][Full Text] [Related]
6. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
7. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
[TBL] [Abstract][Full Text] [Related]
8. Effects of detergents on the secondary structures of prion protein peptides as studied by CD spectroscopy.
Kuroda Y; Maeda Y; Sawa S; Shibata K; Miyamoto K; Nakagawa T
J Pept Sci; 2003 Apr; 9(4):212-20. PubMed ID: 12725242
[TBL] [Abstract][Full Text] [Related]
9. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein.
Mehlhorn I; Groth D; Stöckel J; Moffat B; Reilly D; Yansura D; Willett WS; Baldwin M; Fletterick R; Cohen FE; Vandlen R; Henner D; Prusiner SB
Biochemistry; 1996 Apr; 35(17):5528-37. PubMed ID: 8611544
[TBL] [Abstract][Full Text] [Related]
10. Different structural stability and toxicity of PrP(ARR) and PrP(ARQ) sheep prion protein variants.
Paludi D; Thellung S; Chiovitti K; Corsaro A; Villa V; Russo C; Ianieri A; Bertsch U; Kretzschmar HA; Aceto A; Florio T
J Neurochem; 2007 Dec; 103(6):2291-300. PubMed ID: 17919292
[TBL] [Abstract][Full Text] [Related]
11. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity.
Safar J; Roller PP; Gajdusek DC; Gibbs CJ
Protein Sci; 1993 Dec; 2(12):2206-16. PubMed ID: 7905316
[TBL] [Abstract][Full Text] [Related]
12. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
[TBL] [Abstract][Full Text] [Related]
13. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
Satheeshkumar KS; Jayakumar R
Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
[TBL] [Abstract][Full Text] [Related]
14. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
[TBL] [Abstract][Full Text] [Related]
15. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
Bertho G; Bouvier G; Hoa GH; Girault JP
Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
[TBL] [Abstract][Full Text] [Related]
16. Binding of prion protein to lipid membranes and implications for prion conversion.
Sanghera N; Pinheiro TJ
J Mol Biol; 2002 Feb; 315(5):1241-56. PubMed ID: 11827491
[TBL] [Abstract][Full Text] [Related]
17. The prion protein: Structural features and related toxic peptides.
Ronga L; Tizzano B; Palladino P; Ragone R; Urso E; Maffia M; Ruvo M; Benedetti E; Rossi F
Chem Biol Drug Des; 2006 Sep; 68(3):139-47. PubMed ID: 17062011
[TBL] [Abstract][Full Text] [Related]
18. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
19. [Prion protein structure and its relationships with pathogenesis].
Muramoto T
Rinsho Shinkeigaku; 2003 Nov; 43(11):813-6. PubMed ID: 15152472
[TBL] [Abstract][Full Text] [Related]
20. Assembly of natural and recombinant prion protein into fibrils.
Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
